Sylvia organised a coffee morning to raise funds for Secondary1st in memory of a good friend who had died from secondary breast cancer. 38 people came and enjoyed the morning; they raised more than £400
On October 9th Peter Capaldi, star of “Doctor Who” and Patron of Secondary1st presented a cheque for £75,000 to help fund pioneering research into secondary breast cancer.
Professor Andrew Tutt of King’s College and the Institute
Hannah took part in the Royal Parks Half Marathon on October 8th to raise money for Secondary1st. Research into secondary breast cancer to enable scientists to develop more effective treatments is a cause very close
After a cupcake sale in their offices during the week, on Saturday 9 September a team of intrepid Bristows staff embarked on a 25km walk along the River Thames from Bristows’ offices at 100 Victoria
Do you have any go-to healthy and delicious recipes?
Dishes that make you feel good?
Enter our competition for a chance to share your food and win a Secondary1st t-shirt. Just comment directly on the Secondary1st Facebook
The newly published results of a study conducted by scientists at the Wellcome Trust Sanger Institute and their collaborators show that metastatic breast cancer cells leave the primary tumour at late stages of disease development.
“My advice for friends and family is just to be there”
Kim is 33 years old, married and has two boys aged 3 and 5. Kim was originally diagnosed with primary triple negative breast cancer in
“I just feel very lucky”
Clare is in her fabulous fifties, she is married to her second husband Rob and together they have 3 teenage sons. Tragically, Clare’s first husband Andy died suddenly and unexpectedly at
Our wonderful supporter has knitted many more beautiful hedgehogs to sell, while living with secondary breast cancer. She has now raised an awesome total of £750 for Secondary1st.
The Chief Medical Officer, Dame Sally Davies, has called in her annual report for every cancer patient to have genetic testing. This would lead to personalised treatments being designed for each individual patient. The 100,000